IAI for Persistent DME After Treatment With Bevacizumab And Ranibizumab
- Status
- COMPLETED
- Phase
- PHASE4
Clinical Trials Related to Diabetic Macular Edema
Related studies linked through entity extraction aliases.
iOCT for Patients With Diabetic Macular Edema
- Status
- COMPLETED
- Phase
- NA
DRCR.Net Aflibercept vs. Bevacizumab + Deferred Aflibercept for the Treatment of CI-DME
- Status
- COMPLETED
- Phase
- PHASE3
Assessment of Biomarker Profile in Diabetic Macular Edema With Intravitreal Aflibercept Injection
- Status
- UNKNOWN
- Phase
- N/A
Evaluation of the Effect of Intravitreal Injections of Anti-VEGF on Macular Perfusion in Diabetic Patients Using OCTA
- Status
- COMPLETED
- Phase
- PHASE4
Screening For Diabetic Macular Edema Among Diabetic Patients Using Optical Coherence Tomography
- Status
- UNKNOWN
- Phase
- N/A
Diabetic Macular Edema Asian Response (DEAR) Study: Biomarkers for Response to Aflibercept in Asian Patients With Center Involving DME
- Status
- UNKNOWN
- Phase
- PHASE4
Effect of Levosulpiride on Retinal Alterations in Patients With Diabetic Retinopathy and Diabetic Macular Edema
- Status
- RECRUITING
- Phase
- PHASE2
Diabetic Retinopathy Assessed by Ultra-wide
- Status
- UNKNOWN
- Phase
- N/A
Treatment of Diabetic Macular Edema With Aflibercept and Micropulse Laser
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Suprachoroidal CLS-TA With Intravitreal Aflibercept Versus Aflibercept Alone in Subject With Diabetic Macular Edema
- Status
- COMPLETED
- Phase
- PHASE2
Assessment of EyeArt as an Automated Diabetic Retinopathy Screening Tool
- Status
- COMPLETED
- Phase
- N/A
Analysis of Cytokines in Response to Treatment of Diabetic Macular Edema With 0.3mg Lucentis
- Status
- COMPLETED
- Phase
- PHASE4
PROTECT2: Diabetes Care - Eye Exam
- Status
- UNKNOWN
- Phase
- NA
Intravitreal Alfibercept for Center Involved DME Previously Managed With Intravitreal Ranibizumab
- Status
- WITHDRAWN
- Phase
- PHASE4
Cytokine and Visual Outcome Variations in Eyes Receiving Ranibizumab
- Status
- UNKNOWN
- Phase
- PHASE4
Cytokine and Visual Outcome Variations in Eyes Receiving Aflibercept
- Status
- UNKNOWN
- Phase
- PHASE4
30g vs 33g Needle for Intravitreal Injections
- Status
- COMPLETED
- Phase
- NA
Efficacy of Ozurdex® in the Treatment of Diabetic Macular Edema (DME)
- Status
- COMPLETED
- Phase
- N/A
Bevacizumabe or Triamcinolone for Persistent Diabetic Macular Edema
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3